Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
The three-chamber ‘Combiflex’ lipid bag provides a key source of glucose, amino acid solutions and fat emulsions to patients and children over the age of 2 who are unable to administer nutrition through the oral or enteral route. More
Related Reports
Market Research Reports provided by reports.innovaro.com
May 2009 - 8 pages - $300
Oct 2010 - 8 pages - $500
Feb 2007 - 3 pages - $120
Aug 2011 - 8 pages - $75
Jun 2006 - 19 pages - $1,800
Jul 2010 - 24 pages - $125
Jun 2009 - $4,495
Oct 2008 - $4,495
Nov 2011 - 6 pages - $75
Nov 2011 - 7 pages - $75
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us